Role of the basement membrane in tumor cell dormancy and cytotoxic resistance.

Abstract:

OBJECTIVES AND METHODS:Tumor dormancy and resistance to cytotoxic agents are key limiting events in the treatment of malignant diseases. To determine whether both are influenced by the extracellular milieu in which tumors reside, HT1080 human fibrosarcoma, MCF-7 breast carcinoma and OSCORT osteosarcoma cell proliferation, viability, apoptosis and cytoreductive-treatment-induced death were investigated in the presence or absence of extracellular matrix (ECM). RESULTS:ECM-adherent, but not plastic-adherent HT1080 cells formed a multicellular network accompanied by reduced proliferation and lowered DNA synthetic capacity. The number of cells in S-phase was dramatically reduced. Viable cells entered a state of dormancy reminiscent of that observed in the step of metastasis after extravasation, i.e. prior to the initiation of progressive growth. Such ECM-induced dormancy could be reversed by plating cells on plastic, but only after a 48-hour lag period. No difference was indicated in clonogenicity of HT1080 cells originated from plastic or ECM gel. However, the cells released from ECM gel showed significantly reduced migration ability. The resistance of anchored cells against cytotoxic damage was increased by ECM gel. Examination of cytoreductive treatment revealed that ECM adherence at the time of injury is partially protective, a property which was also moderately apparent when injured cells were transferred to the basement membrane. CONCLUSIONS:Taken together, these results suggest that the ECM plays a key role in tumor dormancy and cytotoxic resistance, both explorable at the molecular level using our in vitro model system.

journal_name

Oncology

journal_title

Oncology

authors

Pogány G,Timár F,Oláh J,Harisi R,Polony G,Paku S,Bocsi J,Jeney A,Laurie GW

doi

10.1159/000055329

subject

Has Abstract

pub_date

2001-01-01 00:00:00

pages

274-81

issue

3

eissn

0030-2414

issn

1423-0232

pii

55329

journal_volume

60

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesis.

    abstract::The present communication reports the inhibitory action of aminoglutethimide on 9,10-dimethyl-1,2-benzanthracene (DMBA) induced mammary carcinogenesis in virgin female Holtzman rats. When 20 mg of DMBA is given to the rats and maintained on normal diet for 32 weeks, approximately 70% of the animals develop mammary tum...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226013

    authors: Rao AR,Das MG,Das P

    更新日期:1985-01-01 00:00:00

  • Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.

    abstract:BACKGROUND:Ethnic disparities in cancers are associated with variability in clinical outcomes. We present a Surveillance Epidemiology and End RESULTS (SEER)-based outcome analysis of multiethnic Waldenström's macroglobulinemia (WM) patients. METHODS:Adult WM patients diagnosed in 1992 or later (n = 3,175) were analyze...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000360992

    authors: Ailawadhi S,Kardosh A,Yang D,Cozen W,Patel G,Alamgir MA,Chanan-Khan AA

    更新日期:2014-01-01 00:00:00

  • Proliferative activity of Hürthle cell thyroid tumours.

    abstract::To improve our understanding of the basic biological mechanisms of Hürthle cell tumours (HCT), proliferative activity in 20 HCT was determined by Ag-NOR (nucleolar organiser regions) counting and by immunohistochemical markers proliferating cell nuclear antigen (PCNA) and MIB-1. Ten surgically removed Hürthle cell ade...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011995

    authors: Cör A

    更新日期:1999-07-01 00:00:00

  • Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies.

    abstract:PURPOSE:This phase I study (EudraCT No. 2006-001177-25) investigated aflibercept, a vascular endothelial growth factor decoy receptor protein (VEGF Trap), in combination with docetaxel, cisplatin, and 5-fluorouracil in patients with advanced solid tumors. PATIENTS AND METHODS:Patients received 2, 4, or 6 mg/kg of intr...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000440958

    authors: Bahleda R,Baker J,Massard C,Gadgeel SM,Rogers JE,Izzedine H,Deutsch E,Garris JL,Khan A,Boelle E,Assadourian S,Soria JC,Ajani JA

    更新日期:2016-01-01 00:00:00

  • Efficacy of Vinorelbine Monotherapy as Third- or Further-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.

    abstract:BACKGROUND:The survival rate of patients with lung cancer has increased significantly over the years, but there has been no further progress in third- or fourth-line therapy. We investigated the efficacy and tolerability of monotherapy with weekly vinorelbine, a semi-synthetic vinca alkaloid, in advanced non-small-cell...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502343

    authors: Kang DH,Kim JO,Jung SS,Park HS,Chung C,Park D,Lee JE

    更新日期:2019-01-01 00:00:00

  • Expression of stanniocalcin 1 as a potential biomarker of gastric cancer.

    abstract:OBJECTIVE:We investigated stanniocalcin 1 (STC 1) expression to assess its clinical utility as a blood marker in patients with gastric cancer and evaluated its biological impact in terms of tumor aggressiveness. METHODS:Blood specimens from 93 patients with gastric cancer and 21 normal healthy volunteers were assessed...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341390

    authors: Arigami T,Uenosono Y,Ishigami S,Hagihara T,Haraguchi N,Matsushita D,Yanagita S,Nakajo A,Okumura H,Hokita S,Natsugoe S

    更新日期:2012-01-01 00:00:00

  • Dose escalation study of paclitaxel in combination with fixed-dose irinotecan in patients with advanced non-small cell lung cancer (JCOG 9807).

    abstract:BACKGROUND:Both irinotecan (CPT) and paclitaxel (Pac) are effective against non-small cell lung cancer (NSCLC), and besides, preclinical studies have demonstrated an additive or synergistic interaction between camptothecin and taxane. METHODS:We conducted a phase I/II study of combination chemotherapy consisting of Pa...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000077434

    authors: Yamada K,Ikehara M,Tanaka G,Nomura I,Oshita F,Noda K

    更新日期:2004-01-01 00:00:00

  • Nasopharyngeal carcinoma and lymphoinfiltration.

    abstract::Originally referred to as 'lymphoepithelioma', undifferentiated and poorly differentiated nasopharyngeal carcinoma (NPC) tissues showed intense lymphoinfiltration. In a study of cryosections from 15 NPC tissues, we found that infiltrating lymphoid elements were comprised predominantly of lymphocytes, but plasma cells,...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226945

    authors: Zong YS,Lin H,Choy DT,Sham JS,Wei W,Chan KH,Ng MH

    更新日期:1991-01-01 00:00:00

  • Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.

    abstract:OBJECTIVE:Ovarian cancer is the most lethal gynecological malignancy, but information relevant to prognosis and outcomes remain unknown. Here, we used statistical methods to focus specifically on interactions between candidate prognostic variables. METHODS AND RESULTS:Univariate, multivariate, and elastic net modeling...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000442710

    authors: Jatoi A,Vierkant RA,Hawthorne KM,Block MS,Ramus SJ,Larson NB,Fridley BL,Goode EL

    更新日期:2016-01-01 00:00:00

  • Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas.

    abstract::Tumor cell apoptosis, proliferation and p27 expression using an in situ apoptosis detection kit, anti-Ki67 antibody and anti-p27 antibody were investigated in 171 colorectal adenocarcinoma specimens, together with the assessment of mutated p53 expression. No apparent association was observed among p27 expression, muta...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012078

    authors: Tenjo T,Toyoda M,Okuda J,Watanabe I,Yamamoto T,Tanaka K,Ohtani M,Nohara T,Kawasaki H,Tanigawa N

    更新日期:2000-01-01 00:00:00

  • Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer.

    abstract::Cyclin D3 promotes cell cycle progression but its expression and prognostic significance in human colorectal cancer is unknown. This study assayed cyclin D3 expression against cell cycle phase fraction and Duke's stage in 35 fresh human primary colorectal cancers. DNA content, cell cycle phase fraction and cyclin D3 e...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011932

    authors: Watson DS,Brotherick I,Shenton BK,Wilson RG,Angus B,Varma JS,Campbell FC

    更新日期:1999-01-01 00:00:00

  • Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinoma.

    abstract:BACKGROUND:The therapeutic potential of chemotherapy in the treatment of recurrent or metastatic non-small cell lung carcinoma (NSCLC) seems modest. Thus, the search for novel agents and combination regimens with a superior therapeutic index has a high priority. The present combination regimen consisting of mitomycin C...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000011909

    authors: Hejna M,Kornek GV,Raderer M,Marosi L,Schneeweiss B,Greul R,Weinländer G,Valencak J,Huber H,Scheithauer W

    更新日期:1998-11-01 00:00:00

  • S100B protein detection in serum is a significant prognostic factor in metastatic melanoma.

    abstract::The serum detection of S100B, a new melanoma marker, has shown clinical significance in early studies. The aim of our study of 1, 339 serum samples from 412 different melanoma patients and 107 control patients was to prove the prognostic value of serum S100B levels in melanoma patients at different stages of disease a...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011989

    authors: Hauschild A,Engel G,Brenner W,Gläser R,Mönig H,Henze E,Christophers E

    更新日期:1999-01-01 00:00:00

  • Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study.

    abstract::In patients affected with different tumours, disorders concerning clotting are frequently observed. The biological processes leading to coagulation are probably involved in the mechanisms of metastasis. We studied plasma levels of thrombin-antithrombin III complexes (TAT) in 90 patients affected with lung tumours subg...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227620

    authors: Tricerri A,Vangeli M,Errani AR,Guidi L,Canetta M,Vaccarino M,De Santis C,Ipsevich F,Salvati F,Bartoloni C

    更新日期:1996-11-01 00:00:00

  • Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.

    abstract:OBJECTIVES:We recently demonstrated that papillary microcarcinomas with preoperatively detectable node metastasis in the lateral compartment on ultrasonography (clinically apparent metastasis) show worse postoperative relapse-free survival than those with no metastasis or metastasis that could not be detected preoperat...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000085701

    authors: Ito Y,Uruno T,Takamura Y,Miya A,Kobayashi K,Matsuzuka F,Kuma K,Miyauchi A

    更新日期:2005-01-01 00:00:00

  • The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancer.

    abstract:OBJECTIVE:The purpose of this study is to investigate whether the Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 (AKAP10) is related to the risk of colorectal cancer (CRC), clinicopathological variables and the environmental factors for the development of CRC. METHODS:Ap...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000201572

    authors: Wang MJ,Zhou ZG,Wang L,Yu YY,Zhang P,Zhang Y,Cui CF,Yang L,Li Y,Zhou B,Sun XF

    更新日期:2009-01-01 00:00:00

  • Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer.

    abstract::The association of MMP-2 (matrix metalloproteinase 2, 72-kD collagenase IV) with invasive and metastatic capacity of tumor cells has implicated a potential role in the prognosis for cancer patients. However, no larger study has been done to prove this hypothesis. The present study was therefore designed to investigate...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011850

    authors: Allgayer H,Babic R,Beyer BC,Grützner KU,Tarabichi A,Schildberg FW,Heiss MM

    更新日期:1998-03-01 00:00:00

  • Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions.

    abstract::Breast cancer is the most common cancer in women. Although survival rates have improved with the use of new therapeutic agents, many issues remain unresolved and new predictive and prognostic factors are needed in clinical practice. Several studies have suggested a prognostic and predictive role for circulating and di...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000215581

    authors: Amadori A,Rossi E,Zamarchi R,Carli P,Pastorelli D,Jirillo A

    更新日期:2009-01-01 00:00:00

  • Administration of vincristine in a patient with Machado-Joseph disease.

    abstract::Chemotherapy-induced peripheral neurotoxicity is a major problem because it represents the dose-limiting side effect of a significant number of antineoplastic drugs, such as vinca alkaloids. Hereditary neuropathies usually predispose to severe vincristine neurotoxicity. Here, we report the case of a 56-year-old man wi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000336602

    authors: Colpo A,Wilson FH,Nardi V,Hochberg E

    更新日期:2012-01-01 00:00:00

  • Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments.

    abstract:OBJECTIVE:New effective therapy is desirable for patients with non-small cell lung cancer (NSCLC) who have failed previous treatments. Fractionated administration of paclitaxel may be less toxic and more active against NSCLC. The aim of this study was to evaluate the activity and toxicity of weekly paclitaxel therapy f...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000079481

    authors: Yasuda K,Igishi T,Kawasaki Y,Kato K,Matsumoto S,Katayama S,Sako T,Shigeoka Y,Suyama H,Sugitani A,Yamamoto M,Hitsuda Y,Shimizu E

    更新日期:2004-01-01 00:00:00

  • Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.

    abstract:PURPOSE:To confirm the safety and effectiveness of techniques to assist radiofrequency ablation (RFA) for difficult cases, we retrospectively evaluated successful treatment rates, early complications and local tumor progressions. PATIENTS AND METHODS:Between June 1999 and April 2009, a total of 341 patients with 535 n...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000315236

    authors: Inoue T,Minami Y,Chung H,Hayaishi S,Ueda T,Tatsumi C,Takita M,Kitai S,Hatanaka K,Ishikawa E,Yada N,Hagiwara S,Ueshima K,Kudo M

    更新日期:2010-07-01 00:00:00

  • In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture.

    abstract::To improve the ability of an in vitro drug sensitivity test to predict in vivo effects, we applied a drug concentration that was pharmacokinetically equivalent to plasma levels and collagen gel droplet-embedded culture with a high cloning efficiency. We reported that the cell-killing effect of cell cycle phase-nonspec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227569

    authors: Inaba M,Tashiro T,Sato S,Ohnishi Y,Tanisaka K,Kobayashi H,Koezuka M

    更新日期:1996-05-01 00:00:00

  • Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.

    abstract::Nicotinamide, the amide derivative of vitamin B(3), cooperates with retinoic acid (RA), a form of vitamin A, and 1,25-dihydroxyvitamin D(3) (D3), to regulate cell differentiation and proliferation of human myeloblastic leukemia cells. In human myeloblastic leukemia cells, RA or D3 are known to cause MAPK signaling lea...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000188664

    authors: Shen M,Yen A

    更新日期:2009-01-01 00:00:00

  • HER-targeted tyrosine-kinase inhibitors.

    abstract::Improved understanding of tumor biology has led to the identification of numerous growth factors that are involved in malignant transformation and tumor progression. Many of these factors induce cellular responses through receptors with intrinsic tyrosine kinase (TK) activity. Therefore, inhibiting receptor TK activit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000066198

    authors: Baselga J,Hammond LA

    更新日期:2002-01-01 00:00:00

  • Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.

    abstract:AIM:The aim of this study was to assess the molecular subtype profiles of male breast cancer (MBC) and subsequent clinical outcome using a validated 6-marker immunohistochemical panel. METHODS:A total of 43 cases of MBC were examined retrospectively using a semiquantitative immunohistochemical analysis of estrogen rec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341537

    authors: Sánchez-Muñoz A,Román-Jobacho A,Pérez-Villa L,Sánchez-Rovira P,Miramón J,Pérez D,Sáez MI,de Luque V,Medina L,Ramírez-Tortosa CL,Vicioso L,Medina JA,Ribelles N,Alba E

    更新日期:2012-01-01 00:00:00

  • Phase II study of UFT plus leucovorin in colorectal cancer.

    abstract::The activity and toxicity of UFT (Tegafur and Uracil) in a 4:1 molar concentration, plus leucovorin (LV), were evaluated in the treatment of 45 patients with advanced, bidimensionally measurable metastatic colorectal carcinoma. Initially 350 and later 300 mg/m2/day, plus 150 mg LV, as administered in divided doses eve...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227741

    authors: Pazdur R

    更新日期:1997-01-01 00:00:00

  • A comparison of ondansetron with alizapride plus methylprednisolone in the control of cisplatin-induced emesis. The French Pneumology Group for the Ondansetron Study.

    abstract::This randomised, single-blind, parallel-group study was carried out in 48 French pneumology centres to compare the anti-emetic efficacy of ondansetron and an alizapride plus methylprednisolone (ALI/MPS) combination in patients receiving high-dose cisplatin. A total of 220 patients were recruited of whom 209 were evalu...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227061

    authors: Depierre A,Lebeau B,d'Allens H

    更新日期:1992-01-01 00:00:00

  • Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.

    abstract::Methyl-CCNU (NSC-95441) was administered to patients with malignant melanoma in a split dose schedule. Nausea and vomiting were eliminated as clinical problems during therapy. Response rate to the drug seemed somewhat lower than the average of three previously reported disease-oriented phase II trials, though the diff...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225178

    authors: Wittes RE,Hong WK,Gatchell L,Krakoff IH,Golbey RB

    更新日期:1977-01-01 00:00:00

  • A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

    abstract:OBJECTIVES:The purpose of this study was to evaluate the antitumor activity and safety of an epirubicin, cisplatin, and capecitabine (ECX) combination in patients with metastatic or advanced gastric cancer. PATIENTS AND METHODS:Patients with metastatic or advanced measurable gastric adenocarcinoma received ECX combina...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1159/000086972

    authors: Cho EK,Lee WK,Im SA,Lee SN,Park SH,Bang SM,Park DK,Park YH,Shin DB,Lee JH

    更新日期:2005-01-01 00:00:00

  • VEGF as a key mediator of angiogenesis in cancer.

    abstract::Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein with a molecular weight of approximately 45 kDa. It is the key mediator of angiogenesis (the formation of new blood vessels), and binds two VEGF receptors (VEGF receptor-1 and VEGF receptor-2), which are expressed on vascular endothelial cells. In...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000088478

    authors: Carmeliet P

    更新日期:2005-01-01 00:00:00